N-[2-(cyclohex-1-en-1-yl)ethyl]-2-[7-(morpholine-4-sulfonyl)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetamide
Chemical Structure Depiction of
N-[2-(cyclohex-1-en-1-yl)ethyl]-2-[7-(morpholine-4-sulfonyl)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetamide
N-[2-(cyclohex-1-en-1-yl)ethyl]-2-[7-(morpholine-4-sulfonyl)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetamide
Compound characteristics
Compound ID: | L707-1189 |
Compound Name: | N-[2-(cyclohex-1-en-1-yl)ethyl]-2-[7-(morpholine-4-sulfonyl)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetamide |
Molecular Weight: | 475.61 |
Molecular Formula: | C24 H33 N3 O5 S |
Smiles: | C1CCC(CCNC(CN2C(CCCc3cc(ccc23)S(N2CCOCC2)(=O)=O)=O)=O)=CC1 |
Stereo: | ACHIRAL |
logP: | 2.3945 |
logD: | 2.3945 |
logSw: | -2.9236 |
Hydrogen bond acceptors count: | 10 |
Hydrogen bond donors count: | 1 |
Polar surface area: | 80.075 |
InChI Key: | KFQXJTHWRVCDKQ-UHFFFAOYSA-N |